A Ceriello, D Johns, M Widel, DJ Eckland, KJ … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS— Postload glycemia and CISI were analyzed for 940
patients who had oral glucose tolerance tests (OGTTs) in four multicenter, randomized,
double-blind, double-dummy, parallel group clinical trials (pioglitazone versus metformin, ... Cited by 28 - Related articles - All 6 versions
MH Tan, NB Glazer, D Johns, M Widel, … - … Medical Research and …, 2004 - informahealthcare.com Background: Miyazaki et al. demonstrated using the hyperinsulinemic, euglycemic clamp that
pioglitazone (PIO) enhanced insulin sensitivity in patients (n = 23) with type 2 diabetes
(T2D). Although considered the reference method for measuring insulin sensitivity, the ... Cited by 22 - Related articles - BL Direct - All 6 versions
MH Tan, A Baksi, B Krahulec, P Kubalski, A … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—This was a randomized, multicenter, double-blind,
double-dummy, parallel-group, 2-year study. Approximately 600 patients from 98 centers
participated. Eligible patients had completed a previous 12-month study and consented to ... Cited by 51 - Related articles - All 6 versions
DR Matthews, BH Charbonnel, M Hanefeld, P … - Diabetes/Metabolism … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 89 - Related articles - All 3 versions
M Hanefeld, P Brunetti, GH Schernthaner, DR … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—HbA 1c was reduced by 1.20% in the SU plus pioglitazone group and 1.36% in the
SU plus metformin group, and fasting plasma glucose was reduced by 2.2 and 2.3 mmol/l in
the respective groups. Fasting insulin levels were also reduced (pioglitazone arm −1.3 ... Cited by 98 - Related articles - BL Direct - All 5 versions
[CITATION] QUARTET Study Group, et al. A long-term comparison of pioglitazone and …
B Charbonnel, M Roden, R Urquhart, S Mariz, D Johns, … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 553–560 DOI 10.1007/s00125-004-1651-9 ARTICLE
B. Charbonnel . M. Roden . R. Urquhart . S. Mariz . D. Johns . M. Mihm . M. Widel . M. Tan
Pioglitazone elicits long-term improvements in insulin sensitivity ... Cited by 9 - Related articles - All 3 versions
G Derosa, AFG Cicero, A Gaddi, PD Ragonesi, MN … - Diabetes research and …, 2005 - Elsevier A total of 87 completed the study (pioglitazone n = 45 or rosiglitazone n = 42). Body mass index
increased after 12 months compared to baseline (p < 0.05) in both groups. A significant decrease
in glycated haemoglobin (HbA 1c ) was observed after 9 (p < 0.05), and 12 (p < 0.01) ... Cited by 61 - Related articles - All 9 versions
L Jovanovic, DR Hassman, B Gooch, R Jain, S … - Diabetes research and …, 2004 - Elsevier The efficacy and safety of combination therapy (repaglinide plus pioglitazone) was compared
to repaglinide or pioglitazone in 24-week treatment of type 2 diabetes. This randomized,
multicenter, open-label, parallel-group study enrolled 246 adults (age 24–85) who had ... Cited by 38 - Related articles - All 4 versions
MH Tan, D Johns, J Strand, J Halse, S … - Diabetic …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 38 - Related articles - BL Direct - All 6 versions
